Published in Endocrinology on August 01, 1997
Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development. J Clin Invest (2007) 1.15
The GNAS Locus: Quintessential Complex Gene Encoding Gsalpha, XLalphas, and other Imprinted Transcripts. Curr Genomics (2007) 0.97
Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma. Oncogene (2010) 0.94
Lessons from mouse models of thyroid cancer. Thyroid (2009) 0.90
Resistance to diet-induced obesity in mice globally overexpressing OGH/GPB5. Proc Natl Acad Sci U S A (2005) 0.85
Mouse models of endocrine tumours. Best Pract Res Clin Endocrinol Metab (2010) 0.78
Modeling thyroid cancer in the mouse. Horm Metab Res (2009) 0.77
Distinguishing molecular markers in thyroid tumors: a tribute to Dr. Orlo Clark. World J Surg (2009) 0.77
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg (1995) 5.66
The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) (1981) 5.29
AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A (2000) 4.37
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg (1997) 3.90
Mandatory second opinion surgical pathology at a large referral hospital. Cancer (1999) 3.40
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res (1996) 3.18
Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med (1990) 3.09
Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet (1996) 3.07
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet (2001) 2.79
Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome. Science (1973) 2.74
Localization of D-lactate dehydrogenase in native and reconstituted Escherichia coli membrane vesicles. J Biol Chem (1975) 2.64
Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res (2001) 2.51
Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A (1992) 2.26
Primary hyperparathyroidism. Lancet (1997) 2.17
Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet (2001) 2.16
Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med (1983) 2.14
Genomic DNA released by dying cells induces the maturation of APCs. J Immunol (2001) 2.03
Bone marrow and spleen: dissociation of immunologic properties by cortisone. Science (1970) 2.02
Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology (2000) 2.01
Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet (2000) 1.92
FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun (2001) 1.90
Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. J Med Genet (2004) 1.85
Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res (1996) 1.80
Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst (1998) 1.78
Procollagen peptidase: an enzyme excising the coordination peptides of procollagen. Proc Natl Acad Sci U S A (1971) 1.73
DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol (1998) 1.71
GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology (2011) 1.69
Serial analysis of gene expression in non-small cell lung cancer. Cancer Res (1998) 1.67
Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab (1998) 1.65
Validity of the in-training examination for predicting American Board of Internal Medicine certifying examination scores. J Gen Intern Med (1992) 1.65
Developing a Canadian prescribing practices network. Network Development Committee of the Canadian Prescribing Practices Network Project. CMAJ (1996) 1.64
Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology (1977) 1.64
Mechanisms of active transport in isolated bacterial membrane vesicles. XV. Purification and properties of the membrane-bound D-lactate dehydrogenase from Escherichia coli. J Biol Chem (1973) 1.60
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano) (2000) 1.59
Primary structure of bovine pituitary secretory protein I (chromogranin A) deduced from the cDNA sequence. Proc Natl Acad Sci U S A (1987) 1.58
Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci U S A (1996) 1.56
Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy. Ann Surg (1991) 1.55
Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun (1980) 1.54
Tetanus toxin interactions with thyroid plasma membranes. Implications for structure and function of tetanus toxin receptors and potential pathophysiological significance. J Biol Chem (1977) 1.53
Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest (1990) 1.52
Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation. Cancer (1999) 1.52
Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck (2000) 1.51
Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors. Proc Natl Acad Sci U S A (1976) 1.48
Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A (1999) 1.48
Multicomponent structure of the thyrotropin receptor: relationship to Graves' disease. Life Sci (1983) 1.48
Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest (2001) 1.48
Specificity of G protein beta and gamma subunit interactions. J Biol Chem (1992) 1.46
Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res (2000) 1.46
Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies. J Clin Endocrinol Metab (1993) 1.46
Repetitive intermittent hypoxia-ischemia and brain damage in neonatal rats. Brain Dev (2000) 1.45
Integrated steady state rate equations and the determination of individual rate constants. J Biol Chem (1975) 1.45
The kinetic properties of spinach leaf glyoxylic acid reductase. J Biol Chem (1970) 1.44
The binding of thyrotropin to isolated bovine thyroid plasma membranes. J Biol Chem (1973) 1.43
Pseudohypoparathyroidism: the molecular basis for hormone resistance--a retrospective. N Engl J Med (1982) 1.42
A pilot survey study to define quality in residency education. Acad Med (2000) 1.41
Partial deficiency of hypoxanthine-guanine phosphoribosyltransferase manifesting as acute renal damage. Intern Med (1998) 1.41
Cloning and characterization of a cDNA that encodes a 70-kDa novel human thyroid autoantigen. J Biol Chem (1989) 1.41
Familial isolated hypoparathyroidism: a molecular genetic analysis of 8 families with 23 affected persons. Medicine (Baltimore) (1986) 1.40
The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease. Thyroid (2000) 1.40
Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells. Endocrinology (1999) 1.39
Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res (2001) 1.39
Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res (1998) 1.39
Evaluation of the association between St. John's wort and elevated thyroid-stimulating hormone. Pharmacotherapy (2001) 1.39
Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds. J Clin Endocrinol Metab (1986) 1.38
Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J Biol Chem (1997) 1.38
Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan. Jpn J Clin Oncol (1998) 1.38
A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. J Clin Endocrinol Metab (2010) 1.37
c-Ha-ras-1 oncogene lies between beta-globin and insulin loci on human chromosome 11p. Am J Hum Genet (1984) 1.37
Thyrotropin effects on thyroid cells in culture. Effects of trypsin on the thyrotropin receptor and on thyrotropin-mediated cyclic 3':5'-AMP changes. J Biol Chem (1975) 1.37
PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol (1999) 1.36
Unresectable hilar cholangiocarcinoma: percutaneous versus operative palliation. Surgery (1994) 1.35
Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res (2001) 1.34
Intrabiliary growth of metastatic colonic adenocarcinoma: a pattern of intrahepatic spread easily confused with primary neoplasia of the biliary tract. Am J Surg Pathol (1997) 1.33
Banding of the pulmonary artery. Results in 111 children. Circulation (1971) 1.33
An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med (1982) 1.33
p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst (1996) 1.32
Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res (2009) 1.31
Profile of a clinical practice: Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons. J Clin Endocrinol Metab (1998) 1.30
Relationships of thyrotropin to exophthalmic-producing substance. Purification of homogeneous glycoproteins containing both activities from [3H]-labeled pituitary extracts. J Biol Chem (1970) 1.29
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations. Neurology (2002) 1.29
The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology (1983) 1.29
Imaging findings of a hibernoma of the neck. AJNR Am J Neuroradiol (2006) 1.28
Quantitative assessment of promoter methylation profiles in thyroid neoplasms. J Clin Endocrinol Metab (2005) 1.27
Clinical implications of guanine nucleotide-binding proteins as receptor-effector couplers. N Engl J Med (1985) 1.27
Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology (2002) 1.27
Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol (1993) 1.26
Thyrotropin receptors in thyroid plasma membranes. Characteristics of thyrotropin binding and solubilization of thyrotropin receptor activity by tryptic digestion. J Biol Chem (1975) 1.24
Effects of thyrotropin on the thyroid cell membrane: hyperpolarization induced by hormone-receptor interaction. Proc Natl Acad Sci U S A (1977) 1.24
Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab (1999) 1.23
Albright hereditary osteodystrophy and del(2) (q37.3) in four unrelated individuals. Am J Med Genet (1995) 1.23
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res (2002) 1.22
Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res (1988) 1.22
Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg (2001) 1.22
Metastatic squamous cell carcinoma to the brain: an unrecognized pattern of distant spread in patients with HPV-related head and neck cancer. J Neurooncol (2013) 1.21
A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol Endocrinol (1999) 1.21
Identification of a SACS gene missense mutation in ARSACS. Neurology (2004) 1.21
Cholera toxin interactions with thyrotropin receptors on thyroid plasma membranes. Proc Natl Acad Sci U S A (1976) 1.20